Wenn das Ziel fehlt: Laschets Problem ist die dritte Sache n-tv.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from n-tv.de Daily Mail and Mail on Sunday newspapers.
are very expensive and going to bring the cost down. jillian: why is it taken this long to get to this point? interesting question and the answer is we have an entitlement, an insurance company doing a deal behind-the-scenes with drug manufacturing. you don t know what the prices and we saw headlines the last couple years where some companies gouged prices and things like epipen zoomed up in price and under those circumstances, may end up allowing importation of drugs and if you gouge patients we will bring it in from another country which is cheaper but we didn t know what these things cost. the prices are hidden from us. jillian: now we are more aware. the president is reading these things are rebelling and the hhs secretary is on it. we will see an impact. competition being key, price transparency being key.